Clinical Trial Update: Safety and Immunogenicity of V114 in Healthy Infants in South Korea (V114-036) [Phase 3]

View source ↗

Summary

Phase 3 trial update reporting safety and immunogenicity data for the 15-valent pneumococcal conjugate vaccine V114 in healthy infants in South Korea (Study V11…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• V114 (15-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-04-15